The Role of Serotonin in Intensive Care Patients

NCT05386199 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2022-05-31

No results posted yet for this study

Summary

Sepsis, cardiac arrest and multiple trauma are potentially life-threatening conditions and common reasons for intensive care unit (ICU) admission. The aim of this study is to investigate the role of the signaling substance serotonin in blood in these conditions.

Conditions

  • Sepsis
  • Septic Shock
  • Cardiac Arrest With Successful Resuscitation
  • Multiple Trauma

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Morten Rostrup, MD PhD · Oslo University Hospital, University of Oslo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-25
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05386199 on ClinicalTrials.gov